ACE2 and COVID-19: While evidence supports ACE2 increase in at least some comorbidities or in response to their associated treatments, it is not possible to conclude on the causality between ACE2 expression levels and the severity of COVID-19 (Pal and Bhadada, 2020; Vaduganathan et al., 2020).